APQUIN AMBIZOLE PLUS AMBIZOLE DARAGON DARAGON MEROLINE IODOMET DI-IODOHYDROXYQUINOLINE M-IODO DIDOMET METODINE METODINE IDOGIL DI-IODOHYDROXYQUINOLINE DI-IODOHYDROXYQUINOLINE DI-IODOHYDROXYQUINOLINE DI-IODOHYDROXYQUINOLINE METOMET METOKIN METOKIN ROSACED FORTE DI-IODOHYDROXYQUINOLONE DI-IODOHYDROXYQUINOLONE DI-IODOHYDROXYQUINOLONE MEGODINE MEGODINE BIOQUIN BIOQUIN BIOQUIN BIOQUIN BIOQUIN BIOQUIN METROZEB METROZEB METOSHIN METOSHIN NIZOLE DINOMET METROSTAT PLUS

Dose: 650 mg
Single Dose: 650 (650)
Frequency: 8 hourly
Route: PO
Instructions: For 15-20 Days

Di-Iodohydroxyquinoline also known as Diodoxyquinoline. . It is of Synthetic origin and belongs to Iodoquinolone. It belongs to Amebicides pharmacological group.The Molecular Weight of Di-Iodohydroxyquinoline is 397.00.

Di-Iodohydroxyquinoline is contraindicated in conditions like Thyroid disease,Blood dyscrasias,Optic neuropathy,Nervous disorders.

The severe or irreversible adverse effects of Di-Iodohydroxyquinoline, which give rise to further complications include Hair loss, Thrombocytopenia, Dermatitis, Neutropenia.The symptomatic adverse reactions produced by Di-Iodohydroxyquinoline are more or less tolerable and if they become severe, they can be treated symptomatically, these include Dizziness, Headache, Drowsiness, Ataxia, Nausea, Vomiting, Diarrhea, Urticaria, Pruritus, Dysuria, Polyuria, Metallic taste, Cystitis, Abdominal discomfort.

Di-Iodohydroxyquinoline is primarily indicated in conditions like Amoebiasis, Amoebic liver abscess, Giardiasis.

No data regarding the interactions of Di-Iodohydroxyquinoline was found.

Drug should not be given to Pregnant Mothers, patients suffering from Kidney dysfunction, and patients suffering from Liver Malfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Tab

Di-iodohydroxyquinolone should be used with caution in patients with thyroid disease. Avoid use in patients with neurological disorder, impaired kidney or liver function, and hypersensitive to iodine or halogenated hydroxyquinolones. Discontinue tyreatment if abnormal neurologic signs appear.